Notice of Interim Results

Assura PLC
31 October 2023
 

31 October 2023

Assura plc

Notice of Interim Results

Assura plc ("the Company"), the UK's leading primary care property investor and developer will announce results for the six months ended 30 September 2023 on Thursday 16 November 2023.

A presentation for analysts and investors, immediately followed by a Q&A with members of the senior management team, can be viewed at 10.00 am GMT at the following link:

https://brrmedia.news/AGR_IR23

- Ends -

 

For more information, please contact:

Assura plc
David Purcell, Investor Relations Director

Tel: 0161 515 2043
Email: Investor@assura.co.uk

Finsbury Glover Hering

Gordon Simpson

Tel: 0207 251 3801
Email: Assura@Finsbury.com

 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Assura (AGR)
UK 100

Latest directors dealings